Cargando…

Development and validation of a novel risk model in newly diagnosed de novo bone metastatic prostate cancer (M1b): a retrospective study

BACKGROUND: Previous studies suggested that bone metastasis has a significant effect on the time of progression to metastatic castration-resistant prostate cancer (CRPC) for newly diagnosed de novo bone metastatic hormone-sensitive prostate cancer (mHSPC). Nevertheless, the effect of different bone...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yang, Wang, Junqi, Ding, Li, Zheng, Yuxin, Wu, Chuang, Wang, Kun, Xia, Wentao, Ge, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840864/
https://www.ncbi.nlm.nih.gov/pubmed/36650836
http://dx.doi.org/10.7717/peerj.14615